Greenphire Enhances Its Participant Payment and Reimbursement Solution to Further Support Remote Clinical Trials

As the COVID-19 pandemic continues to limit movement all over the world, clinical trials have had to adapt by leveraging methodologies typically associated with hybrid or remote clinical trial designs.

NSF-funded Smartphone COVID-19 Diagnostic Test Could Put Testing in the Hands of the Public

A smartphone diagnostic test for COVID-19 being developed by a University of Utah researcher holds the potential for quick, accurate testing without the need for individuals to go to a healthcare facility.

Sterling Pharma Solutions commence the production of potential COVID-19 treatment

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has commenced production of hydroxychloroquine, a treatment currently under investigation for COVID-19.

Abbott Earns Emergency Use Authorization for Another COVID-19 Antibody Test

Abbott Laboratories has won EUA Authorization for another COVID-19-related diagnostics test for antibodies. This morning, the company said the U.S. FDA approved its SARS-CoV-2 IgG lab...

Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received approval from India's drug...

Catalent Partners with Humanigen to Support FDA-Approved Phase 3 Lenzilumab Study for COVID-19

Catalent welcomed the news by Humanigen that it has dosed the first COVID-19 patient in its previously announced Phase 3 study for lenzilumab, the company’s proprietary Humaneered anti-human...

Vibalogics announces collaboration to provide additional clinical trial material for covid-19 vaccine candidate

Vibalogics announced that it will manufacture additional clinical trial material for the lead COVID-19 vaccine candidate currently in development by the Janssen Pharmaceutical Companies of ....

Pfizer & BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program

Pfizer Inc. and BioNTech SE announced that the first participants have been dosed in the U.S. in the Phase 1/ 2 clinical trial for the BNT162 vaccine program to prevent COVID-19.

Thermo Fisher Scientific to Double its Capacity of Viral Vector Manufacturing

Thermo Fisher Scientific Inc announced it is expanding capacity for viral vector development and manufacturing services with construction of a new commercial manufacturing site in Plainville, Mass.

Word Pharma Today brings you an exclusive interview with Jim Murphy, CEO, Greenphire Inc., who talks us through his company's outlook within the Pharma world, the stretch his workforce has shown in the current challenging environment, and the state-of-the-art ConneX Patient Direct solution, which enables clinical trial sponsors and sites to conduct trials without any disruption.